SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

被引:0
|
作者
Constanze Schneider
Thomas Oellerich
Hanna-Mari Baldauf
Sarah-Marie Schwarz
Dominique Thomas
Robert Flick
Hanibal Bohnenberger
Lars Kaderali
Lena Stegmann
Anjali Cremer
Margarethe Martin
Julian Lohmeyer
Martin Michaelis
Veit Hornung
Christoph Schliemann
Wolfgang E Berdel
Wolfgang Hartmann
Eva Wardelmann
Federico Comoglio
Martin-Leo Hansmann
Alexander F Yakunin
Gerd Geisslinger
Philipp Ströbel
Nerea Ferreirós
Hubert Serve
Oliver T Keppler
Jindrich Cinatl
机构
[1] Institute of Medical Virology,Department of Medicine II
[2] University of Frankfurt,Cambridge University Department of Haematology
[3] Hematology and Oncology,Department of Virology
[4] ,Department of Chemical Engineering and Applied Chemistry
[5] Goethe University of Frankfurt,Gene Center and Department of Biochemistry
[6] Cambridge Institute of Medical Research,Department of Medicine A (Hematology
[7] German Cancer Consortium partner site,undefined
[8] German Cancer Research Center,undefined
[9] Max von Pettenkofer Institute,undefined
[10] Ludwig Maximilian University of Munich,undefined
[11] Pharmazentrum frankfurt/ZAFES,undefined
[12] ,undefined
[13] Institute of Clinical Pharmacology,undefined
[14] Goethe University of Frankfurt,undefined
[15] University of Toronto,undefined
[16] Institute of Pathology,undefined
[17] University Medical Center,undefined
[18] Institute of Bioinformatics,undefined
[19] University Medicine Greifswald,undefined
[20] Centre for Molecular Processing and School of Biosciences,undefined
[21] University of Kent,undefined
[22] Institute of Molecular Medicine,undefined
[23] University Hospital Bonn,undefined
[24] Ludwig Maximilian University of Munich,undefined
[25] Oncology),undefined
[26] University Hospital Münster,undefined
[27] Gerhard Domagk Institute for Pathology,undefined
[28] University Hospital Münster,undefined
[29] Senckenberg Institute of Pathology,undefined
[30] University of Frankfurt,undefined
[31] Fraunhofer Institute for Molecular Biology and Applied Ecology (IME),undefined
[32] Project Group Translational Medicine and Pharmacology (TMP),undefined
来源
Nature Medicine | 2017年 / 23卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The therapeutic response of acute myeloid leukemia to the nucleoside analog Ara-C is controlled by SAMHD1, an enzyme that hydrolyzes the active metabolite Ara-CTP.
引用
收藏
页码:250 / 255
页数:5
相关论文
共 50 条
  • [1] SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
    Schneider, Constanze
    Oellerich, Thomas
    Baldauf, Hanna-Mari
    Schwarz, Sarah-Marie
    Thomas, Dominique
    Flick, Robert
    Bohnenberger, Hanibal
    Kaderali, Lars
    Stegmann, Lena
    Cremer, Anjali
    Martin, Margarethe
    Lohmeyer, Julian
    Michaelis, Martin
    Hornung, Veit
    Schliemann, Christoph
    Berdel, Wolfgang E.
    Hartmann, Wolfgang
    Wardelmann, Eva
    Comoglio, Federico
    Hansmann, Martin-Leo
    Yakunin, Alexander F.
    Geisslinger, Gerd
    Stroebel, Philipp
    Ferreiros, Nerea
    Serve, Hubert
    Keppler, Oliver T.
    Cinatl, Jindrich, Jr.
    NATURE MEDICINE, 2017, 23 (02) : 250 - 255
  • [2] Correction: Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
    Constanze Schneider
    Thomas Oellerich
    Hanna-Mari Baldauf
    Sarah-Marie Schwarz
    Dominique Thomas
    Robert Flick
    Hanibal Bohnenberger
    Lars Kaderali
    Lena Stegmann
    Anjali Cremer
    Margarethe Martin
    Julian Lohmeyer
    Martin Michaelis
    Veit Hornung
    Christoph Schliemann
    Wolfgang E Berdel
    Wolfgang Hartmann
    Eva Wardelmann
    Federico Comoglio
    Martin-Leo Hansmann
    Alexander F Yakunin
    Gerd Geisslinger
    Philipp Ströbel
    Nerea Ferreirós
    Hubert Serve
    Oliver T Keppler
    Jindrich Cinatl
    Nature Medicine, 2017, 23 : 788 - 788
  • [3] SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia (vol 23, pg 250, 2017)
    Schneider, Constanze
    Oellerich, Thomas
    Baldauf, Hanna-Mari
    Schwarz, Sarah-Marie
    Thomas, Dominique
    Flick, Robert
    Bohnenberger, Hanibal
    Kaderali, Lars
    Stegmann, Lena
    Cremer, Anjali
    Martin, Margarethe
    Lohmeyer, Julian
    Michaelis, Martin
    Hornung, Veit
    Schliemann, Christoph
    Berdel, Wolfgang E.
    Hartmann, Wolfgang
    Wardelmann, Eva
    Comoglio, Federico
    Hansmann, Martin-Leo
    Yakunin, Alexander F.
    Geisslinger, Gerd
    Strobel, Philipp
    Ferreiros, Nerea
    Serve, Hubert
    Keppler, Oliver T.
    Cinatl, Jindrich, Jr.
    NATURE MEDICINE, 2017, 23 (06) : 788 - 788
  • [4] Evidence for SAMHD1 Tumor Suppressor Functions in Acute Myeloid Leukemia
    Schaller, Torsten
    Herold, Nikolas
    ACTA HAEMATOLOGICA, 2020, 143 (01) : 7 - 8
  • [5] SAMHD1 is a Novel Biomarker and Therapeutic Target for Radiation Therapy and PARP Inhibition
    Schlafstein, A.
    Daddacha, W.
    Kowalski, J.
    Yu, D. S.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2017, 58 : S83 - S83
  • [6] Repurposing Old Drugs as SAMHD1 Inhibitors to Improve Efficacy of Cytarabine in Paediatric Acute Myeloid Leukaemia
    Rudd, S. G.
    Paulin, C. B.
    Nikolaos, T.
    Sanjiv, K.
    Juliane, K.
    Myrberg, I. Hed
    Axelsson, H.
    Rasti, A.
    Witta, E.
    Lee, S.
    Rassidakis, G. Z.
    Tamm, K. Pokrovskaja
    Heyman, M.
    Grander, D.
    Lundback, T.
    Lehmann, S.
    Helleday, T.
    Henter, J. I.
    Schaller, T.
    Herold, N.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S419 - S420
  • [7] Targeting SAMHD1 Promotes Anti-Tumor Immunity in Acute Myeloid Leukemia
    Zhang, Lei
    Dong, Haojie
    He, Xin
    Lin, Yichun
    Hu, Weidong
    Salhotra, Amandeep
    Armenian, Saro H.
    Marcucci, Guido
    Luo, Yun
    Li, Ling
    BLOOD, 2022, 140
  • [8] SAMHD1 is a Novel Biomarker and Therapeutic Target for Radiation Therapy and PARP Inhibition in Breast Cancer
    Thompson, Elizabeth
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients
    Jiang, Huinan
    Li, Chuan
    Liu, Zhuogang
    Hu, Rong
    ACTA HAEMATOLOGICA, 2020, 143 (01) : 51 - 59
  • [10] The Spliceosome As a New Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia
    Luz Morales, Maira
    Garcia-Vicente, Roberto
    Rodriguez Garcia, Alba
    Alvarez Sanchez-Redondo, Noemi
    Ortiz-Ruiz, Alejandra
    Reyes-Palomares, Armando
    Sanchez, Ricardo
    Garrido-Garcia, Vanesa
    Carreno-Tarragona, Gonzalo
    Hermouet, Sylvie
    Ayala, Rosa
    Martinez Lopez, Joaquin
    Linares, Maria
    BLOOD, 2021, 138